Tevogen Bio (NASDAQ:TVGN) Now Covered by Analysts at D. Boral Capital
D. Boral Capital began coverage on shares of Tevogen Bio (NASDAQ:TVGN – Get Free Report) in a research report issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $10.00 price target on the stock. Tevogen Bio Stock Down 6.3 % Shares of NASDAQ TVGN opened at $1.19 on Tuesday. The business […]
